[Treatment of later phases of Parkinson disease].
Tison
F
F
Département de neurologie, CHU de Bordeaux, GH Sud, Hôpital Haut-Lévêque, Bordeaux. francois.tison@chu-bordeaux.fr
D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003704:Dementia / Q000209:etiology / Q000523:psychology; D018491:Dopamine Agonists / Q000009:adverse effects / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced / Q000503:physiopathology; D006801:Humans; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy* / Q000523:psychology
D000978:Antiparkinson Agents; D018491:Dopamine Agonists